Regulation of PCSK9 by nutraceuticals.

Momtazi, Amir Abbas; Banach, Maciej; Pirro, Matteo; Katsiki, Niki; Sahebkar, Amirhossein

Momtazi, Amir Abbas; Banach, Maciej; Pirro, Matteo; Katsiki, Niki; Sahebkar, Amirhossein.

Afiliación

Momtazi AA; Nanotechnology Research Center, Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Banach M; Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, Lodz, Poland; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.
Pirro M; Unit of Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Medicine, University of Perugia, Perugia, Italy.
Katsiki N; Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece.
Sahebkar A; Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran; Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. Electronic address: sahebkara@mums.ac.ir.

Pharmacol Res ; 120: 157-169, 2017 Jun.

Article en En | MEDLINE | ID: mdl-28363723

Asunto(s)

Anticolesterolemiantes/farmacología; Suplementos Dietéticos; Inhibidores Enzimáticos/farmacología; Inhibidores de PCSK9; Proproteína Convertasa 9/metabolismo; Transducción de Señal/efectos de los fármacos; Animales; Anticolesterolemiantes/uso terapéutico; LDL-Colesterol/sangre; LDL-Colesterol/metabolismo; Suplementos Dietéticos/análisis; Inhibidores Enzimáticos/uso terapéutico; Humanos; Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología; Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico; Proproteína Convertasa 9/genética; Activación Transcripcional/efectos de los fármacos

Palabras clave

3-hydroxy-3-methylglutaryl-coenzyme A; ALA; APMF; ASCVD; ApoB; ApoER2; CGN; COMIT; DHA; DPA; Docosapentaenoic acid; EGF-A; EPA; ER; FH; GK; HMG-CoA; HNF1; HeFH; LDL; LDL-C; LPS; PCSK9; alpha-linolenic acid; apolipoprotein B; apolipoprotein E receptor2; aqueous extract of PM fruit;; atherosclerotic cardiovascular disease; berberine; canola oil multicenter intervention trial; cerebellar granule neurons; curcumin; docosahexaenoic acid; eicosapentaenoic acid; endoplasmic reticulum; epidermal growth factor-like repeat A; familial hypercholesterolemia; glucokinase; hepatocyte nuclear factor1; heterozygous familial hypercholesterolemia; hyperlipidemia; lipopolysaccharide; low-density lipoprotein; phytochemical

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Suplementos Dietéticos / Inhibidores Enzimáticos / Proproteína Convertasa 9 / Inhibidores de PCSK9 / Anticolesterolemiantes Límite: Animals / Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google